Table 3.
Nominal logistic regression models showing outcome measures that are associated with active clinical disease in patients with LVV.
| Predictor Variable | Univariable Models |
Multivariable Model |
|||||
|---|---|---|---|---|---|---|---|
| Parameter Estimate | Standard Error | p-value | Parameter Estimate | Std β-Estimate | Standard Error | p-value | |
| MFI | 0.081 | 0.035 | 0.019 | 0.068 | 0.290 | 0.265 | 0.273 |
| PtGlobal | 0.255 | 0.058 | <0.001 | 0.246 | 0.592 | 0.251 | 0.018 |
| SF-36 PCS | −0.040 | 0.013 | 0.003 | −0.001 | 0.011 | 0.252 | 0.965 |
| BIPQ | 0.026 | 0.010 | 0.011 | −0.003 | −0.048 | 0.234 | 0.839 |
| CRP | 0.030 | 0.009 | <0.001 | 0.036 | 0.660 | 0.323 | 0.041 |
| PETVAS | 0.117 | 0.025 | <0.001 | 0.158 | 0.976 | 0.220 | <0.001 |
| SF-36 MCS | −0.018 | 0.012 | 0.129 | ||||
| Diagnosis (TAK) | −0.229 | 0.251 | 0.362 | ||||
MFI= Multi-dimensional fatigue inventory; PtGlobal= Patient Global Assessment; SF-36 PCS= 36-item short form health survey physical component summary score; BIPQ= brief illness perception questionnaire; CRP= c-reactive protein; PETVAS= qualitative score of vascular FDG-PET activity; SF-36 MCS= 36-item short form health survey mental component summary score; TAK= Takayasu’s arteritis.